Articolul precedent |
Articolul urmator |
140 12 |
Ultima descărcare din IBN: 2024-04-15 15:17 |
SM ISO690:2012 DUDA, Boris, AXENTI, Alin, BRAGARU, Artur, POGONEA, Sergiu. Aetoxysklerol in the treatment of symptomatic simple renal cysts. In: Perspectives of the Balkan medicine in the post COVID-19 era: The 37th Balkan Medical Week. The 8th congress on urology, dialysis and kidney transplant from the Republic of Moldova “New Horizons in Urology”, Ed. 37, 7-9 iunie 2023, Chişinău. București: Balkan Medical Union, 2023, Ediția 37, p. 28. ISSN Print: ISSN 1584-9244 ISSN-L 1584-9244 Online: ISSN 2558-815X. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Perspectives of the Balkan medicine in the post COVID-19 era Ediția 37, 2023 |
||||||
Congresul "Perspectives of the Balkan medicine in the post COVID-19 era" 37, Chişinău, Moldova, 7-9 iunie 2023 | ||||||
|
||||||
Pag. 28-28 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Introduction. Percutaneous aspiration sclerotherapy is indicated for the treatment of symptomatic renal cysts. The efficacy of various sclerosing agents have been sources of ongoing debate and disagreement. Purpose of the study. The aim of this study was to evaluate the efficacy and safety of the use of aethoxysklerol 3% in the minimally invasive treatment of simple renal cysts. Material and methods. Between 2018 and 2021, the results of 43 symptomatic patients with an average age of 55 years, of which 22 men and 21 women, with renal cysts larger than 5 cm, detected on ultrasonography or CT Bosniak I. Under local anaesthesia, through a percutaneous ultrasound guided approach with an 18G needle, puncture the collection with aspiration of the liquid, then inject 1.0 ml of aetoxysklerol 3% solution for every 100 ml of aspirated liquid. Results. The complete disappearance of the renal cyst varied between 80% - 96% after a follow-up period of 3-36 months, for cysts up to 7.0 cm. The partial reduction of the renal cyst >50% varied between 35% - 55%. Minor complications 2 cases 4.6%: low fever and microhematuria. The success rate of sclerotherapy was inversely proportional to cyst size (p=0.01). Conclusions. Sclerotherapy with aetoxysklerol 3% is a more reliable, cost-effective minimally invasive method for the treatment of simple renal cysts. |
||||||
|